Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Wildlife Health Market Size & Growth Forecast 2026–2035, By Segments (End-use, Animal Type, Product, Route of Administration), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14510| Published Date: Jun-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Wildlife Health Market size was worth USD 2.82 Billion in 2025 and is expected to grow at a 10% CAGR between 2026 and 2035, surpassing USD 7.31 Billion by 2035. The industry revenue for 2026 is assessed at USD 3.07 billion.

Base Year Value (2025)
USD 2.82 Billion
CAGR (2026-2035)
10%
Forecast Year Value (2035)
USD 7.31 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Wildlife Health Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 32.40% market share in 2025 due to established veterinary infrastructure, structured wildlife disease surveillance, and coordinated conservation and animal health programs supporting continuous market demand.
  • Asia Pacific is projected to grow at an 11.3% CAGR, supported by stronger biodiversity protection efforts, expanding disease surveillance programs, and increased investment in wildlife veterinary capacity.

Segment Momentum

  • Zoos accounted for 32.4% of the market in 2025 because they require continuous veterinary care, disease surveillance, preventive treatment, and long-term health management across diverse captive wildlife populations.
  • Birds are the fastest-growing animal type as rising injury cases, habitat disruption, migratory stress, and disease surveillance needs increase demand for specialized rehabilitation and monitoring services.

Market Expansion Drivers

  • Rising zoonotic disease surveillance and One Health initiatives strengthening wildlife monitoring systems.
  • Government funding for avian influenza preparedness expanding wildlife healthcare infrastructure.
  • Expansion of wildlife rehabilitation centers and veterinary facilities improving care delivery networks.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Leading companies in the wildlife health market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Virbac S.A. (France), IDEXX Laboratories, Inc. (United States), Wedgewood Pharmacy (United States), Jorgensen Laboratories, Inc. (United States), Tecnovax S.A. (Argentina), Hallowell EMC (United States), NexGen Pharmaceuticals, Inc. (United States), Elanco Animal Health Incorporated (United States).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising zoonotic disease surveillance and One Health initiatives strengthening wildlife monitoring systems

As zoonotic risk management becomes more integrated into public health planning, the wildlife health market is seeing stronger demand for surveillance tools, field diagnostics, pathogen screening, and coordinated animal health services. One Health programs connect wildlife agencies, veterinary teams, environmental authorities, and disease laboratories, which turns wildlife monitoring from a fragmented conservation activity into a more structured health function with recurring procurement needs. This trend influences market adoption by increasing routine sampling, case reporting, and health assessment of wild populations, while also aiding market expansion for data-driven monitoring systems and specialized veterinary interventions tied to early outbreak detection.

Government funding for avian influenza preparedness expanding wildlife healthcare infrastructure

Targeted public funding for avian influenza preparedness is translating into practical capacity expansion for the wildlife health market through investments in testing networks, emergency response capability, mobile field equipment, and specialized treatment and containment resources for wild bird populations. These allocations often improve the operational readiness of wildlife hospitals, diagnostic labs, and field surveillance programs, creating sustained purchasing activity beyond one-time outbreak response. As preparedness programs formalize protocols for detection, handling, quarantine, and reporting, they reinforce market demand for veterinary consumables, biosafety systems, and wildlife disease management services linked to avian health monitoring.

Expansion of wildlife rehabilitation centers and veterinary facilities improving care delivery networks

The growth of rehabilitation centers and dedicated veterinary facilities is improving access points for diagnosis, treatment, recovery, and long-term monitoring, which directly strengthens service delivery in the wildlife health market. A broader care network increases the number of animals entering formal health systems rather than remaining outside observation, leading to higher utilization of imaging, laboratory testing, surgical care, pharmaceuticals, and post-release assessment. This practical expansion of treatment infrastructure supports market penetration by making wildlife healthcare more operationally consistent, while also encouraging referral pathways and specialized clinical capabilities that were previously limited by geography or facility availability.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Wildlife disease surveillance and prevention programs 3.00% Short term (≤ 2 yrs) North America, Europe (spillover: Asia Pacific) High Fast
Government and NGO conservation initiatives 2.00% Medium term (2–5 yrs) Europe, Asia Pacific (spillover: North America) Medium Moderate
Adoption of advanced diagnostics and vaccines for wildlife 1.00% Long term (5+ yrs) North America, Europe (spillover: Asia Pacific) Medium Slow
Rising zoonotic disease surveillance and One Health initiatives strengthening wildlife monitoring systems 2.30% High North America, Asia Pacific High Near Term
Government funding for avian influenza preparedness expanding wildlife healthcare infrastructure 2.10% High North America, Europe High Near Term
Expansion of wildlife rehabilitation centers and veterinary facilities improving care delivery networks 1.80% Moderate Asia Pacific, North America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
32.40% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 32.40% share of the wildlife health market in 2025, backed by established veterinary infrastructure, structured wildlife disease surveillance, and sustained coordination between conservation bodies, research institutions, and animal health agencies. This leadership is aided by the region’s practical ability to detect, monitor, and manage health threats across wild animal populations through laboratory networks, field diagnostics, and organized intervention programs. Market activity remains strong because procurement and use are tied to ongoing monitoring of zoonotic risks, habitat-linked disease pressures, and rehabilitation needs, creating steady demand for vaccines, diagnostics, therapeutics, and related services.

Asia Pacific is projected to expand at an 11.3% CAGR over the forecast period, with the wildlife health market gaining momentum as countries intensify attention on biodiversity protection, emerging disease monitoring, and veterinary capacity for wild species. Growth is being fueled by rising deployment of surveillance programs in ecologically sensitive zones and a broader push to improve response systems for cross-species disease transmission. In practice, this is translating into greater adoption of diagnostic tools, field treatment support, and health management programs where wildlife-human-livestock interfaces are becoming more closely monitored.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Conservation Health Programs

Germany prioritizes wildlife disease management within broader biodiversity and ecosystem protection initiatives. German institutions are expanding surveillance of infectious diseases in wild species and supporting research programs focused on population health and habitat resilience.

France 🇫🇷

One Health Coordination

France increasingly applies a One Health approach to wildlife management by linking environmental monitoring with animal and human health priorities. French agencies are supporting disease surveillance programs and research initiatives focused on emerging pathogens in wildlife populations.

Italy 🇮🇹

Biodiversity Protection Measures

Italy is strengthening wildlife health activities through conservation programs and veterinary monitoring of protected species. The market in Italy is supported by initiatives aimed at disease prevention, habitat management, and improved coordination between environmental and animal health authorities.

Japan 🇯🇵

Ecosystem Monitoring Focus

Japan is increasing attention on wildlife health management to address changing ecosystems and disease risks. Authorities in Japan are strengthening monitoring programs and veterinary interventions aimed at protecting native species and reducing potential transmission to domestic animals.

South Korea 🇰🇷

Biosecurity Preparedness

South Korea's wildlife health market is influenced by concerns around transboundary animal diseases and ecological preservation. The country is investing in surveillance capabilities and diagnostic infrastructure to improve early detection and response to wildlife-related health threats.

United States 🇺🇸

Integrated Disease Surveillance

The U.S. wildlife health market is centered on monitoring zoonotic diseases and strengthening coordination between veterinary, environmental, and public health agencies. Investments in the U.S. continue to support diagnostics, disease tracking systems, and conservation-focused veterinary services.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Wildlife Health Market Share (%), End-use, 2025

Zoos
Wildlife Sanctuaries
Wildlife Rescue & Rehab Centers
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
End-use Segment Analysis: Zoos (Largest Segment) vs Wildlife Rescue & Rehab Centers (Fastest-Growing Segment)

Zoos held the dominant position in the wildlife health market in 2025, accounting for a 32.4% share. Their leadership is maintained through the need for continuous veterinary oversight, preventive care, disease surveillance, and long-term health management across diverse captive species populations. Unlike short-duration care settings, zoos operate with structured animal health programs and recurring treatment requirements, which keeps demand steady across diagnostics, therapeutics, and monitoring services in the wildlife health market.

Wildlife Rescue & Rehab Centers are emerging as the fastest-growing end-use segment in the wildlife health market as the volume of injured, displaced, and human-impacted wild animals increases the need for rapid clinical intervention and rehabilitation support. Growth is being reinforced by the practical nature of these facilities, which handle acute care, stabilization, and release-oriented treatment pathways that require flexible and responsive health solutions. Compared with more established end-use settings, these centers are gaining momentum because their role is expanding directly in response to real-time wildlife emergencies and recovery needs.

Animal Type Segment Analysis: Mammals (Largest Segment) vs Birds (Fastest-Growing Segment)

By 2025, mammals represented the largest animal type segment in the wildlife health market, with a 47.7% share. This leadership reflects the broad health management needs associated with mammalian species across conservation facilities, zoos, and treatment settings, where ongoing care often involves complex diagnostics, trauma management, and disease control. The mammals segment maintains its share because these species frequently require intensive veterinary attention and sustained medical oversight, creating consistent demand across the wildlife health market.

Birds are the fastest-growing animal type segment in the wildlife health market, supported by rising treatment needs linked to injury, habitat disruption, migratory stress, and infectious disease monitoring. Their growth is encouraged by the increasing requirement for specialized handling, rehabilitation, and surveillance in care environments that are seeing greater avian case volumes. Relative to other animal types, birds are gaining momentum as wildlife health systems respond to more frequent rescue, monitoring, and recovery interventions involving avian populations.

Segment Sub-Segment Largest Segment Fastest Growing
End-use Zoos, Wildlife Sanctuaries, Wildlife Rescue & Rehab Centers, Others Zoos Wildlife Rescue & Rehab Centers
Animal Type Mammals, Birds, Fish, Reptiles, Amphibians Mammals Birds
Product Medicine, Equipment & Consumables Medicine Equipment & Consumables
Route of Administration Oral, Injectable, Others Injectable Oral
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the wildlife health market:

1. Zoetis Inc. (United States)

2. Boehringer Ingelheim International GmbH (Germany)

3. Virbac S.A. (France)

4. IDEXX Laboratories Inc. (United States)

5. Wedgewood Pharmacy (United States)

6. Jorgensen Laboratories Inc. (United States)

7. Tecnovax S.A. (Argentina)

8. Hallowell EMC (United States)

9. NexGen Pharmaceuticals Inc. (United States)

10. Elanco Animal Health Incorporated (United States)

Increasing focus on biodiversity protection is strengthening diagnostic and therapeutic innovation in the wildlife health market. In the wildlife health market, improved disease monitoring systems and advanced veterinary interventions are enhancing ecosystem health management.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Zoological Society of London May-26 London Zoo is constructing a £20 million wildlife health centre that integrates clinical veterinary infrastructure with public engagement. The facility features glass-partitioned viewing areas for observational education, representing a significant advancement in zoological veterinary infrastructure designed to enhance both medical treatment capabilities for wild animals and public awareness of conservation medicine.
World Veterinary Association Mar-26 The World Veterinary Association and Action for Animal Health are advocating for increased global investment in animal health systems, specifically targeting the UN High-Level Meeting on Pandemic Prevention. This initiative aims to drive sustained funding toward essential veterinary services, diagnostics, vaccine development, and professional workforce training to bolster global pandemic preparedness.
WOAH Jan-26 The World Organisation for Animal Health (WOAH) released new operational guidelines focused on mitigating disease transmission risks at the wildlife-livestock interface. This framework establishes improved biosecurity standards and disease prevention protocols, intended to facilitate safer global trade while reducing the economic and health impacts of transboundary animal diseases and zoonotic pathogens.
Cornell University Nov-25 Cornell University launched an ACZM-approved residency program in wildlife population health to address the growing demand for specialized conservation medicine. By integrating clinical veterinary expertise with population-level ecology, the program aims to professionalize the management of free-ranging wildlife health and improve institutional response capabilities for emerging infectious diseases.
International Livestock Research Institute Mar-25 The International Livestock Research Institute, in partnership with the World Organisation for Animal Health, introduced a new operational framework to integrate wildlife health into global One Health systems. This initiative promotes the wider adoption of standardized surveillance tools, diagnostic pharmaceuticals, and coordinated disease management protocols to mitigate zoonotic risks on a global scale.
Global Biodefense Jun-25 Global Biodefense introduced a minimum data standard for wildlife disease research, addressing critical needs for data interoperability and transparency. This initiative supports the development of robust, early-warning surveillance systems for zoonotic diseases, facilitating more consistent data utilization and strengthening global pandemic preparedness through improved wildlife health monitoring and research accuracy.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Wildlife Health Market — Custom Segments

Segment Sub-Segment
No segment data available.

Wildlife Health Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How much revenue does the wildlife health market generate?

As of 2026 the market size of wildlife health is valued at USD 3.07 billion.

What is the forecasted size of the wildlife health industry?

Wildlife Health Market size is projected to expand significantly moving from USD 2.82 billion in 2025 to USD 7.31 billion by 2035 with a CAGR of 10% during the 2026-2035 forecast period.

How is zoonotic disease surveillance and One Health coordination influencing wildlife health system demand?

One Health initiatives are strengthening structured wildlife monitoring by linking veterinary teams, laboratories, and environmental agencies. This increases routine surveillance, diagnostic testing, and pathogen tracking, driving steady procurement of vaccines, diagnostics, and field monitoring tools across coordinated wildlife health systems.

What is driving the rapid expansion of wildlife rescue and rehabilitation-based healthcare demand?

Wildlife rescue and rehab centers are expanding due to rising cases of injured and displaced animals requiring acute care and stabilization. These facilities increase demand for flexible treatment solutions, diagnostics, and rehabilitation support tied directly to emergency wildlife response and recovery workflows.

Why are zoos the largest end-use segment in the wildlife health market?

Zoos accounted for 32.4% of the market in 2025 because they require continuous veterinary care, disease surveillance, preventive treatment, and long-term health management across diverse captive wildlife populations.

Which animal type is growing the fastest in the wildlife health market?

Birds are the fastest-growing animal type as rising injury cases, habitat disruption, migratory stress, and disease surveillance needs increase demand for specialized rehabilitation and monitoring services.

Why does North America lead the wildlife health market?

North America held a 32.40% market share in 2025 due to established veterinary infrastructure, structured wildlife disease surveillance, and coordinated conservation and animal health programs supporting continuous market demand.

What is fueling wildlife health market growth in Asia Pacific?

Asia Pacific is projected to grow at an 11.3% CAGR, supported by stronger biodiversity protection efforts, expanding disease surveillance programs, and increased investment in wildlife veterinary capacity.

What are the prominent companies operating in the wildlife health landscape?

Leading companies in the wildlife health market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Virbac S.A. (France), IDEXX Laboratories, Inc. (United States), Wedgewood Pharmacy (United States), Jorgensen Laboratories, Inc. (United States), Tecnovax S.A. (Argentina), Hallowell EMC (United States), NexGen Pharmaceuticals, Inc. (United States), Elanco Animal Health Incorporated (United States).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →